Medicare & Medicaid

A discussion about the Medicare Drug Price Negotiation Program with Adina Lasser, director of public policy and government affairs with the Alliance for Aging Research.

A discussion about the Medicare Drug Price Negotiation Program with Adina Lasser, director of public policy and government affairs with the Alliance for Aging Research.

A discussion about the Medicare Drug Price Negotiation Program with Adina Lasser, director of public policy and government affairs with the Alliance for Aging Research.

A discussion about the Medicare Drug Price Negotiation Program with Adina Lasser, director of public policy and government affairs with the Alliance for Aging Research.

A discussion about the Medicare Drug Price Negotiation Program with Adina Lasser, director of public policy and government affairs with the Alliance for Aging Research.

A discussion about the Medicare Drug Price Negotiation Program with Adina Lasser, director of public policy and government affairs with the Alliance for Aging Research.

Congress could rectify the situation in upcoming spending bill or with pending legislation.

Legislators question Health and Human Services leaders about potential for wrongful disclosure of private health information.

Gallup, Emory University post findings about highest priorities for government leaders right now.

Risk-adjusted monthly payments better align funding with the needs of high-risk primary care patients, UMass Chan study finds.

WSJ: Department of Government Efficiency examines payment and contracting systems.

Comments on 2026 rule include suggestions on behavioral health, AI and more.

Meeting includes statements for and against Kennedy, known for vaccine skepticism.

Amid mounting evidence of GLP-1 receptor agonists’ efficacy as weight loss drugs, ACP calls on policymakers to ensure access for patients in need.

A slideshow with statements of support.

Legislation could counter total 6.43% budget cut, but time is ticking away, doctors say.

The Senate Health, Education, Labor and Pensions Committee pressed Kennedy on past comments regarding vaccine safety, Medicare knowledge and drug pricing as confirmation vote looms.

Administration, advocates could find common ground with opportunities to improve health care for physicians and patients.

President’s priorities are not changing, and there was to be no pause to Medicaid and some other spending programs, White House says.

White House says assistance going directly to people won’t be affected by temporary pause.

News outlets report opposition to Robert F. Kennedy Jr. over vaccines, reproductive issues and more.

By helping family physicians, the new Congress and administration would bolster health care across the nation.

The potential CMS model would set a $2 copayment for common generic drugs in an effort to improve medication adherence.

Democrats claim credit, vow to fight against repeal; patient advocacy group offers critique.

President-elect Donald Trump takes office on Jan. 20. MGMA says this is what he and Congress should focus on for health care.

New prices would take effect in 2027.

Choice is up to Congress, but plan presents a raise for 2026, with additional money for primary care.

Rep. Greg Murphy, MD (R-North Carolina), discusses reforms he hopes Congress will consider this year.

Rep. Greg Murphy, MD (R-North Carolina), discusses reforms he hopes Congress will consider this year.

Rep. Greg Murphy, MD (R-North Carolina), discusses reforms he hopes Congress will consider this year.